Clinical opinion published in American Journal of Obstetrics & Gynecology

Dr. Charles Rardin contributes to the debate over the use of robotics for minimally invasive gynecologic surgery

2014-05-01

(Press-News.org) When a woman requires gynecologic surgery, she and her surgeon have several minimally invasive surgical options, including robotic surgery. In recent years, the use of robotic surgery has become more and more common. But questions have arisen about the potential overuse of robotic surgery and its advantages over traditional laparotomy for hysterectomy.

A clinical opinion by Charles Rardin, MD, a urogynecologist in the Division of Urogynecology and Reconstructive Surgery and director of the Robotic Surgery Program for Women at Women & Infants Hospital of Rhode Island, director of Minimally Invasive Surgery at Care New England, and associate professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University, entitled "The debate over robotics in benign gynecology," is published this month in the American Journal of Obstetrics & Gynecology.

"Robotic surgery certainly provides some advantages to some surgeons and has contributed to a decline in laparotomy (large incision) rates for hysterectomy," said Dr. Rardin. "But robotic surgery for benign gynecology needs to be considered as just one of several forms of minimally invasive surgery (MIS) that can be used to provide the best care to patients."

Dr. Rardin explained that specific features of the patient (ie obesity), the surgeon (ie his or her experience with laparoscopic surgery), or the case (ie the possibility of significant and technically challenging suturing, such as required for a fistula repair) may make the robotic approach preferable over laparoscopic or vaginal surgery.

"However, an institution that adopts a policy of promoting robotic surgery over other forms of minimally invasive surgery is at risk of becoming a 'robotic factory' and allowing volume and quality of vaginal or laparoscopic surgeries to dwindle," he said.

In his opinion piece, Dr. Rardin suggests that other organizations consider the approach taken at the Care New England hospitals (Kent, Memorial and Women & Infants), which focuses on the ability to provide the full spectrum of MIS procedures to each individual patient presenting for surgical care. He outlines how hospitals and physicians could promote a balanced approach to MIS by considering four issues: The development of rigorous and self-determined processes of quality management and feedback to surgical staff, as well as credentialing systems based on training, skills, peer support, and ongoing volume The development of case criteria, reserving the use of the robot to cases in which specifics of the patient, the surgeon or the case warrant it The ability to identify and address imbalances in surgical technique by monitoring the use and relative rates of MIS techniques for gynecology as well as the related patient outcomes data Providing structure and support for all forms of MIS, not just robotics, for trainees (residents and fellows) as well as those who have already completed formal training programs

This year, Women & Infants Hospital was designated a Center of Excellence in Minimally Invasive Gynecology (COEMIG) by the Surgical Review Corporation, an affiliate of the American Association of Gynecologic Laparoscopists (AAGL), for its commitment to offering women the most effective diagnostic and therapeutic techniques in minimally invasive surgery.

Covering the full spectrum of the specialty, American Journal of Obstetrics & Gynecology, "The Gray Journal," presents the latest diagnostic procedures, leading-edge research, and expert commentary in maternal-fetal medicine, reproductive endocrinology and infertility, gynecologic oncology, and urogynecology, as well as general obstetrics and gynecology.

INFORMATION: About Women & Infants Hospital Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the eighth largest stand-alone obstetrical service in the country with nearly 8,400 deliveries per year. In 2009, Women & Infants opened the country's largest, single-family room neonatal intensive care unit.

New England's premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the National Institutes of Health's Pelvic Floor Disorders Network.

ELSE PRESS RELEASES FROM THIS DATE:

Standard assessments miss early signs of cardiovascular disease in firefighters

2014-05-01

Traditional first-line checks of such heart disease risk factors as cholesterol, blood pressure and smoking habits aren't nearly good enough to identify cardiovascular disease in otherwise healthy, young firefighters, according to results of a small Johns Hopkins study. Previous studies have found that cardiovascular disease accounts for 45 percent of deaths of on-duty firefighters nationwide, in contrast to 15 percent of deaths among those with conventional occupations, with heart attack being the number one cause of death. The Johns Hopkins researchers designed their ...

Amphibians in a vice: Climate change robs frogs, salamanders of refuge

2014-05-01

By hightailing it to nearby ponds and shallow waterways, frogs and salamanders have – until now – had a way to evade exotic trout introduced to the West's high-mountain lakes for recreational fishing. A warming climate, however, will dry up some of the places where amphibians and their young have found refuge. Researchers in the May 1 issue of Frontiers in Ecology and the Environment write about this challenge and a novel combination of tools that could help land managers, biologists, fishing enthusiasts and other citizens weigh where amphibians are in the most need of ...

New discovery: Molecule links asthma and cancer and could aid in developing new treatments

2014-05-01

A newly discovered molecule provides a new drug target for controlling both asthma-induced muscle thickening and cancerous tumor growth. This molecule, called "microRNA-10a," normally helps genes produce proteins or make copies of themselves, also play an important role in the growth or overgrowth of human airway smooth muscle cells and some forms of cancer. This newly discovered role, which was published in the May 2014 issue of The FASEB Journal, suggests that manipulating microRNA-10a could lead to new asthma and cancer drugs. "We hope this study will serve as the ...

Killing Kindlin-3 to cure breast cancer: 'Blood' protein implicated

2014-05-01

A protein believed to be limited to the hematopoietic system, called Kindlin-3, has been identified as a major player in both the formation and spread of breast cancer to other organs. This discovery, published in the May 2014 issue of The FASEB Journal, could open the door to an entirely new class of breast cancer drugs that targets this protein's newly found activity. "Kill Kindlin-3 to cure cancer," said Elzbieta Pluskota, Ph.D., a researcher involved in the work from the Department of Molecular Cardiology at the Cleveland Clinic Lerner Research Institute in Cleveland, ...

Monitoring, management, and oversight critical for responsible shale gas development

2014-05-01

Ottawa (May 1st, 2014) – A new expert panel report, Environmental Impacts of Shale Gas Extraction in Canada, concludes that shale gas development must be supported by well-targeted science and management strategies to understand and mitigate potential impacts. The report, released today by the Council of Canadian Academies, addresses environmental and associated health impacts and offers insights regarding public engagement and trust. Shale gas is leading an energy boom which is having profound economic, environmental, and social impacts across much of North America. ...

Rules of thumb: 3 simple ideas for overcoming childhood obesity

2014-05-01

New Orleans, LA – Kristopher Kaliebe, MD, Clinical Assistant Professor of Psychiatry at the LSU Health Sciences Center New Orleans School of Medicine, offers parents and caregivers three simple family-oriented goals to overcome the complex problem of childhood obesity and related mental disorders. They involve limit setting to address the brain's "get more" drive strengthened through habitual over-consumption of temptations including highly caloric processed food, hyper-reality media and electronics, as well as excessive sitting. His 3 "rules" of living promote physical ...

Individual brain activity predicts tendency to succumb to daily temptations

2014-05-01

Activity in areas of the brain related to reward and self-control may offer neural markers that predict whether people are likely to resist or give in to temptations, like food, in daily life, according to research in Psychological Science, a journal of the Association for Psychological Science. "Most people have difficulty resisting temptation at least occasionally, even if what tempts them differs," say psychological scientists Rich Lopez and Todd Heatherton of Dartmouth College, authors on the study. "The overarching motivation of our work is to understand why some ...

Antimicrobial edible films inhibit pathogens in meat

2014-05-01

Antimicrobial agents incorporated into edible films applied to foods to seal in flavor, freshness and color can improve the microbiological safety of meats, according to researchers in Penn State's College of Agricultural Sciences. Using films made of pullulan -- an edible, mostly tasteless, transparent polymer produced by the fungus Aureobasidium pulluns -- researchers evaluated the effectiveness of films containing essential oils derived from rosemary, oregano and nanoparticles against foodborne pathogens associated with meat and poultry. The results demonstrate that ...

Researchers find the accelerator for molecular machines

2014-05-01

How hard can it be to make a wheel rotate in a machine? Very hard actually, when the wheel sits in one of those nano-small molecular machines that are predicted to be running our future machines. But before the molecular machines become part of our daily lives, researchers must be able to control them. A Danish/American research team have now solved part of this problem. There are large machines and there are small machines - and then there are molecular machines. They are nano-tiny collections of molecular building blocks that together make up a machine and operate various ...

Unlocking a mystery of thalidomide

2014-05-01

In the 1950s and 1960s, pregnant women with morning sickness were often prescribed the new drug thalidomide. Shortly after the medicine was released on the market, a reported 10,000 infants were born with an extreme form of the rare congenital phocomelia syndrome, which caused death in 50 percent of cases and severe physical and mental disabilities in others. Although various factors are now known to cause phocomelia, the prominent roots of the disease can be found in the use of the drug thalidomide. Now, half a century later, new research by Dr. Noam Shomron, Prof ...